Cholesterol metabolism in drug‑resistant cancer (Review)
- Authors:
- Aiwen Yan
- Zhirong Jia
- Chen Qiao
- Meisa Wang
- Xuansheng Ding
-
Affiliations: School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 211198, P.R. China, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 211198, P.R. China, Precision Medicine Laboratory, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 211198, P.R. China - Published online on: September 22, 2020 https://doi.org/10.3892/ijo.2020.5124
- Pages: 1103-1115
This article is mentioned in:
Abstract
 |
 |
|
Global Burden of Disease Cancer Collaboration; Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I, et al: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 5:1749–1768. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Fojo A, Hamilton TC, Young RC and Ozols RF: Multidrug resistance in ovarian cancer. Cancer. 60:2075–2080. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Yang F, Gao B, Li R, Li W, Chen W, Yu Z and Zhang J: Expression levels of resistant genes affect cervical cancer prognosis. Mol Med Rep. 15:2802–2806. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chun SY, Kwon YS, Nam KS and Kim S: Lapatinib enhances the cytotoxic effects of doxorubicin in MCF-7 tumorspheres by inhibiting the drug efflux function of ABC transporters. Biomed Pharmacother. 72:37–43. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
International Transporter Consortium; Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, et al: Membrane transporters in drug development. Nat Rev Drug Discov. 9:215–236. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Longley DB and Johnston PG: Molecular mechanisms of drug resistance. J Pathol. 205:275–292. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Bedi A, Barber JP, Bedi GC, el-Deiry WS, Sidransky D, Vala MS, Akhtar AJ, Hilton J and Jones RJ: BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: A mechanism of resistance to multiple anticancer agents. Blood. 86:1148–1158. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Camidge DR, Pao W and Sequist LV: Acquired resistance to TKIs in solid tumours: Learning from lung cancer. Nat Rev Clin Oncol. 11:473–481. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Maier S, Dahlstroem C, Haefliger C, Plum A and Piepenbrock C: Identifying DNA methylation biomarkers of cancer drug response. Am J Pharmacogenomics. 5:223–232. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Taylor ST, Hickman JA and Dive C: Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors. J Natl Cancer Inst. 92:18–23. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Maxfield FR and Tabas I: Role of cholesterol and lipid organization in disease. Nature. 438:612–621. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Gabitova L, Gorin A and Astsaturov I: Molecular pathways: Sterols and receptor signaling in cancer. Clin Cancer Res. 20:28–34. 2014. View Article : Google Scholar | |
|
Zhang P, Wang D, Zhao Y, Ren S, Gao K, Ye Z, Wang S, Pan CW, Zhu Y, Yan Y, et al: Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabi-lization and AKT-mTORC1 activation. Nat Med. 23:1055–1062. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wu Y, Si R, Tang H, He Z, Zhu H, Wang L, Fan Y, Xia S, He Z and Wang Q: Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma. Biochem Biophyes Res Commun. 457:614–620. 2015. View Article : Google Scholar | |
|
Sperling CD, Verdoodt F, Hansen MK, Dehlendorff C, Friis S and Kjaer SK: Statin use and mortality among endometrial cancer patients: A danish nationwide cohort study. Int J Cancer. 143:2668–2676. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Murtola TJ, Peltomaa AI, Talala K, Määttänen L, Taari K, Tammela TL and Auvinen A: Statin use and prostate cancer survival in the finnish randomized study of screening for prostate cancer. Eur Urol Focus. 3:212–220. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Rezen T, Rozman D, Pascussi JM and Monostory K: Interplay between cholesterol and drug metabolism. Biochim Biophys Acta. 1814:146–160. 2011. View Article : Google Scholar | |
|
Cerqueira NM, Oliveira EF, Gesto DS, Santos-Martins D, Moreira C, Moorthy HN, Ramos MJ and Fernandes PA: Cholesterol biosynthesis: A mechanistic overview. Biochemistry. 55:5483–5506. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bloch K: Summing up. Ann Rev Biochem. 56:1–19. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Goldstein JL and Brown MS: Regulation of the mevalonate pathway. Nature. 343:425–430. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Williamson IP and Kekwick RG: The formation of 5-phospho-mevalonate by mevalonate kinase in hevea brasiliensis latex. Biochem J. 96:862–871. 1965. View Article : Google Scholar : PubMed/NCBI | |
|
Ačimovič J and Rozman D: Steroidal triterpenes of cholesterol synthesis. Molecules. 18:4002–4017. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Brown MS and Goldstein JL: Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res. 21:505–517. 1980.PubMed/NCBI | |
|
Gilardi F, Mitro N, Godio C, Scotti E, Caruso D, Crestani M and De Fabiani E: The pharmacological exploitation of cholesterol 7alpha-hydroxylase, the key enzyme in bile acid synthesis: From binding resins to chromatin remodelling to reduce plasma cholesterol. Pharmacol Ther. 116:449–472. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Sakakura Y, Shimano H, Sone H, Takahashi A, Inoue N, Toyoshima H, Suzuki S and Yamada N: Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis. Biochem Biophys Res Commun. 286:176–183. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Montero J, Morales A, Llacuna L, Lluis JM, Terrones O, Basañez G, Antonsson B, Prieto J, García-Ruiz C, Colell A, et al: Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma. Cancer Res. 68:5246–5256. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Weber P, Wagner M and Schneckenburger H: Cholesterol dependent uptake and interaction of doxorubicin in MCF-7 breast cancer cells. Int J Mol Sci. 14:8358–8366. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen QF, Pan ZZ, Zhao M, Wang Q, Qiao C, Miao L and Ding X: High cholesterol in lipid rafts reduces the sensitivity to EGFR-TKI therapy in non-small cell lung cancer. J Cell Physiol. 233:6722–6732. 2018. View Article : Google Scholar | |
|
Yun UJ, Lee JH, Shim J, Yoon K, Goh SH, Yi EH, Ye SK, Lee JS, Lee H, Park J, et al: Anti-Cancer effect of doxorubicin is mediated by downregulation of HMG-Co A reductase via inhibition of EGFR/Src pathway. Lab Invest. 99:1157–1172. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Greife A, Tukova J, Steinhoff C, Scott SD, Schulz WA and Hatina J: Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation. Tumor Biol. 36:3293–3300. 2015. View Article : Google Scholar | |
|
Kong YF, Cheng LJ, Mao FY, Zhang ZZ, Zhang YQ, Farah E, Bosler J, Bai YF, Ahmad N, Kuang S, et al: Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC). J Biol Chem. 293:14328–14341. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kim YN, Jin H, He Y, Zhao P, Hu Y, Tao J, Chen J and Huang Y: Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery. Theranostics. 9:265–278. 2019. View Article : Google Scholar | |
|
Gupta VK, Sharma NS, Kesh K, Dauer P, Nomura A, Giri B, Dudeja V and Banerjee S, Bhattacharya S, Saluja A and Banerjee S: Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity. Cancer Lett. 439:101–112. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Glod kowska-M rowka E, M rowka P, Basa k GW, Niesiobedzka-Krezel J, Seferynska I, Wlodarski PK, Jakobisiak M and Stoklosa T: Statins inhibit ABCB1 and ABCG2 drug trans-porter activity in chronic myeloid leukemia cells and potentiate antileukemic effects of imatinib. Exp Hematol. 42:439–447. 2014. View Article : Google Scholar | |
|
Chen Y, Liu G, Guo L, Wang H, Fu Y and Luo Y: Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration. Int J Cancer. 136:182–194. 2015. View Article : Google Scholar | |
|
Chen X, Liu Y, Wu J, Huang HR, Du ZY, Zhang K, Zhou DY, Hung K, Goodin S and Zheng X: Mechanistic study of inhibitory effects of atorvastatin and docetaxel in combination on prostate cancer. Cancer Genomics Proteomics. 13:151–160. 2016.PubMed/NCBI | |
|
Brown MS and Goldstein JL: Receptor-Mediated control of cholesterol metabolism. Science. 191:150–154. 1976. View Article : Google Scholar : PubMed/NCBI | |
|
Brown MS and Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science. 232:34–47. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH and Krieger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271:518–520. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Landschulz KT, Pathak RK, Rigotti A, Krieger M and Hobbs HH: Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest. 98:984–995. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Betters JL and Yu L: NPC1L1 and cholesterol transport. FEBS Lett. 584:2740–2747. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Rader DJ, Alexander ET, Weibel GL, Billheimer J and Rothblat GH: The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res. 50(Suppl): S189–S194. 2009. View Article : Google Scholar : | |
|
Maranghi M, Truglio G, Gallo A, Grieco E, Verrienti A, Montali A, Gallo P, Alesini F, Arca M and Lucarelli M: A novel splicing mutation in the ABCA1 gene, causing tangier disease and familial HDL deficiency in a large family. Biochem Biophys Res Commun. 508:487–493. 2019. View Article : Google Scholar | |
|
Vedhachalam C, Duong PT, Nickel M, Nguyen D, Dhanasekaran P, Saito H, Rothblat GH, Lund-Katz S and Phillips MC: Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. J Biol Chem. 282:25123–25130. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Gelissen IC, Harris M, Rye KA, Quinn C, Brown AJ, Kockx M, Cartland S, Packianathan M, Kritharides L and Jessup W: ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol. 26:534–540. 2006. View Article : Google Scholar | |
|
Jessup W, Gelissen IC, Gaus K and Kritharides L: Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macro-phages. Curr Opin Lipidol. 17:247–257. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Mitsche MA, Lutjohann D, Cohen JC, Xie XS and Hobbs HH: Relative roles of ABCG5/ABCG8 in liver and intestine. J Lipid Res. 56:319–330. 2015. View Article : Google Scholar : | |
|
Connelly MA and Williams DL: Scavenger receptor BI: A scavenger receptor with a mission to transport high density lipo-protein lipids. Curr Opin Lipidol. 15:287–295. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Huang ZH, Gu D, Lange Y and Mazzone T: Expression of scavenger receptor BI facilitates sterol movement between the plasma membrane and the endoplasmic reticulum in macrophages. Biochemistry. 42:3949–3955. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Calkin AC and Tontonoz P: Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol. 13:213–224. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Goldstein JL, DeBose-Boyd RA and Brown MS: Protein sensors for membrane sterols. Cell. 124:35–46. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Brown MS and Goldstein JL: The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 89:331–340. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Shimano H: SREBPs: Physiology and pathophysiology of the SREBP family. FEBS J. 276:616–621. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Radhakrishnan A, Goldstein JL, McDonald JG and Brown MS: Switch-Like control of SREBP-2 transport triggered by small changes in ER cholesterol: A delicate balance. Cell Metab. 8:512–521. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lo Sasso G, Murzilli S, Salvatore L, D'Errico I, Petruzzelli M, Conca P, Jiang ZY, Calabresi L, Parini P and Moschetta A: Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis. Cell Metab. 12:187–193. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Duval C, Touche V, Tailleux A, Fruchart JC, Fievet C, Clavey V, Staels B and Lestavel S: Niemann-Pick C1 like 1 gene expression is downregulated by LXR activators in the intestine. Biochem Biophys Res Commun. 340:1259–1263. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Cancer Genome Atlas Research Network; Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C and Stuart JM: The cancer genome atlas pan-cancer analysis project. Nat Genet. 45:1113–1120. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kuzu OF, Noory MA and Robertson GP: The role of cholesterol in cancer. Cancer Res. 76:2063–2070. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Li JJ, Qu XC, Tian J, Zhang JT and Cheng JX: Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation. PLoS One. 13:e01933182018. View Article : Google Scholar : PubMed/NCBI | |
|
Hultsch S, Kankainen M, Paavolainen L, Kovanen RM, Ikonen E, Kangaspeska S, Pietiäinen V and Kallioniemi O: Association of tamoxifen resistance and lipid reprogramming in breast cancer. BMC Cancer. 18:8502018. View Article : Google Scholar : PubMed/NCBI | |
|
May GL, Wright LC, Dyne M, Mackinnon WB, Fox RM and Mountford CE: Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts. Int J Cancer. 42:728–733. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Nguyen VT, Barozzi I, Faronato M, Lombardo Y, Steel JH, Patel N, Darbre P, Castellano L, Győrffy B, Woodley L, et al: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion. Nat Commun. 6:100442015. View Article : Google Scholar : PubMed/NCBI | |
|
Souchek JJ, Baine MJ, Lin C, Rachagani S, Gupta S, Kaur S, Lester K, Zheng D, Chen S, Smith L, et al: Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation. Br J Cancer. 111:1139–1149. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bandyopadhyay S, Li J, Traer E, Tyner JW, Zhou A, Oh ST and Cheng JX: Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia. PLoS One. 12:e01795582017. View Article : Google Scholar : PubMed/NCBI | |
|
Dominguez-Perez M, Simoni-Nieves A, Rosales P, Nuño-Lámbarri N, Rosas-Lemus M, Souza V, Miranda RU, Bucio L, Carvajal SU, Marquardt JU, et al: Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosis. J Cell Physiol. 234:7213–7223. 2019. View Article : Google Scholar | |
|
Smith B and Land H: Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Rep. 2:580–590. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Crain RC, Clark RW and Harvey BE: Role of lipid transfer proteins in the abnormal lipid content of morris hepatoma mitochondria and microsomes. Cancer Res. 43:3197–3202. 1983.PubMed/NCBI | |
|
Yamamoto Y, Tomiyama A, Sasaki N, Yamaguchi H, Shirakihara T, Nakashima T, Kumagai K, Takeuchi S, Toyooka T, Otani N, et al: Intracellular cholesterol level regulates sensitivity of glioblastoma cells against temozolo-mide-induced cell death by modulation of caspase-8 activation via death receptor 5-accumulation and activation in the plasma membrane lipid raft. Biochem Biophys Res Commun. 495:1292–1299. 2018. View Article : Google Scholar | |
|
Ikonen E: Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol. 9:125–138. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Pike LJ: Lipid rafts: Heterogeneity on the high seas. Biochem J. 378:281–292. 2004. View Article : Google Scholar | |
|
Li YC, Park MJ, Ye SK, Kim CW and Kim YN: Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. Am J Pathol. 168:1107–1118. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Vieira AV, Lamaze C and Schmid SL: Control of EGF receptor signaling by clathrin-mediated endocytosis. Science. 274:2086–2089. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Sigismund S, Argenzio E, Tosoni D, Cavallaro E, Polo S and Di Fiore PP: Clathrin-Mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev Cell. 15:209–219. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang S, Wang X, Song D, Liu X, Gu Y, Xu Z, Wang X, Zhang X, Ye Q, Tong Z, et al: Cholesterol induces epithelial-to-mesenchymal transition of prostate cancer cells by suppressing degradation of EGFR through APMAP. Cancer Res. 15:3063–3075. 2019. View Article : Google Scholar | |
|
Su YJ, Lin WH, Chang YW, Wei KC, Liang CL, Chen SC and Lee JL: Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3 beta/beta-catenin signaling required for maintenance of cancer stem cell properties. Oncotarget. 6:38029–38045. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Prieto-Vila M, Takahashi RU, Usuba W, Kohama I and Ochiya T: Drug resistance driven by cancer stem cells and their niche. Int J Mol Sci. 18:25742017. View Article : Google Scholar | |
|
Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, et al: Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 293:2449–2452. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Chatterjee M, Ben-Josef E, Thomas DG, Morgan MA, Zalupski MM, Khan G, Andrew Robinson C, Griffith KA, Chen CS, Ludwig T, et al: Caveolin-1 is associated with tumor progression and confers a multi-modality resistance phenotype in pancreatic cancer. Sci Rep. 5:108672015. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Wang N, Huang C, Bao Y, Jiang Y and Zhu G: Downregulation of caveolin-1 increases the sensitivity of drug-resistant colorectal cancer HCT116 cells to 5-fluorouracil. Oncol Lett. 13:483–487. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Karantanos T, Karanika S, Wang J, Yang G, Dobashi M, Park S, Ren C, Li L, Basourakos SP, Hoang A, et al: Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer. Oncotarget. 7:46321–46334. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mohammad N, Malvi P, Meena AS, Singh SV, Chaube B, Vannuruswamy G, Kulkarni MJ and Bhat MK: Cholesterol depletion by methyl-beta-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma. Mol Cancer. 13:2042014. View Article : Google Scholar | |
|
Troost J, Albermann N, Haefeli WE and Weiss J: Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells. Biochem Biophys Res Commun. 316:705–711. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Rothnie A, Theron D, Soceneantu L, Martin C, Traikia M, Berridge G, Higgins CF, Devaux PF and Callaghan R: The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence. Eur Biophys J. 30:430–442. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Kamau SW, Krämer SD, Günthert M and Wunderli-Allenspach H: Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells. In Vitro Cell Dev Anim. 41:207–216. 2005. View Article : Google Scholar | |
|
Gayet L, Dayan G, Barakat S, Labialle S, Michaud M, Cogne S, Mazane A, Coleman AW, Rigal D and Baggetto LG: Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells. Biochemistry. 44:4499–4509. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Eckford PD and Sharom FJ: Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: Effects on ATPase activity, drug binding and transport. Biochemistry. 47:13686–13698. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Subramanian N, Schumann-Gillett A, Mark AE and O'Mara ML: Understanding the accumulation of P-glycoprotein substrates within cells: The effect of cholesterol on membrane partitioning. Biochim Biophys Acta. 1858:776–782. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Gelsomino G, Corsetto PA, Campia I, Montorfano G, Kopecka J, Castella B, Gazzano E, Ghigo D, Rizzo AM and Riganti C: Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition. Mol Cancer. 12:1372013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen W, Zhang YW, Li Y, Zhang JW, Zhang T, Fu BS, Zhang Q and Jiang N: Constitutive expression of wnt/betacatenin target genes promotes proliferation and invasion of liver cancer stem cells. Mol Med Rep. 13:3466–3474. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Pál A, Méhn D, Molnár E, Gedey S, Mészáros P, Nagy T, Glavinas H, Janáky T, von Richter O, Báthori G, et al: Cholesterol potentiates ABCG2 activity in a heterologous expression system: Improved in vitro model to study function of human ABCG2. J Pharmacol Exp Ther. 321:1085–1094. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Telbisz A, Müller M, Ozvegy-Laczka C, Homolya L, Szente L, Váradi A and Sarkadi B: Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter. Biochem Biophys Acta. 1768:2698–2713. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Takano M, Higashi M, Ito H, Toyota S, Hirabayashi Y and Yumoto R: Functional expression of breast cancer resistance protein and cholesterol effect in human erythrocyte membranes. Pharmazie. 73:700–705. 2018.PubMed/NCBI | |
|
Marbeuf-Gueye C, Stierle V, Sudwan P, Salerno M and Garnier-Suillerot A: Perturbation of membrane microdomains in GLC4 multidrug-resistant lung cancer cells-modification of ABCC1 (MRP1) localization and functionality. FEBS J. 274:1470–1480. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Pallarés-Trujillo J, Domènech C, Grau-Oliete MR and Rivera-Fillat MP: Role of cell cholesterol in modulating vincristine uptake and resistance. Int J Cancer. 55:667–671. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Rivel T, Ramseyer C and Yesylevskyy S: The asymmetry of plasma membranes and their cholesterol content influence the uptake of cisplatin. Sci Rep. 9:56272019. View Article : Google Scholar : PubMed/NCBI | |
|
Sharma B, Gupta V, Dahiya D, Kumar H, Vaiphei K and Agnihotri N: Clinical relevance of cholesterol homeostasis genes in colorectal cancer. Biochim Biophys Acta Mol Cell Biol Lipids. 1864:1314–1327. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Simigdala N, Gao Q, Pancholi S, Roberg-Larsen H, Zvelebil M, Ribas R, Folkerd E, Thompson A, Bhamra A, Dowsett M and Martin LA: Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer. Breast Cancer Res. 18:582016. View Article : Google Scholar : PubMed/NCBI | |
|
Kimbung S, Lettiero B, Feldt M, Bosch A and Borgquist S: High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer. Oncotarget. 7:59640–59651. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kim S, Lee M, Dhanasekaran DN and Song YS: Activation of LXRa/beta by cholesterol in malignant ascites promotes chemo-resistance in ovarian cancer. BMC Cancer. 18:12322018. View Article : Google Scholar | |
|
Zhou P, Li B, Liu B, Chen T and Xiao J: Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: A systematic review and meta-analysis. Clin Chim Acta. 477:94–104. 2018. View Article : Google Scholar | |
|
Rodrigues Dos Santos C, Fonseca I, Dias S and de Almeida JC: Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression. BMC Cancer. 14:1322014. View Article : Google Scholar : PubMed/NCBI | |
|
Lofterød T, Mortensen ES, Nalwoga H, Wilsgaard T, Frydenberg H, Risberg T, Eggen AE, McTiernan A, Aziz S, Wist EA, et al: Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. BMC Cancer. 18:6542018. View Article : Google Scholar : PubMed/NCBI | |
|
Wulaningsih W, Vahdaninia M, Rowley M, Holmberg L, Garmo H, Malmstrom H, Lambe M, Hammar N, Walldius G, Jungner I, et al: Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: A competing risk analysis. BMC Cancer. 15:9132015. View Article : Google Scholar : PubMed/NCBI | |
|
Tamura T, Inagawa S, Hisakura K, Enomoto T and Ohkohchi N: Evaluation of serum high-density lipoprotein cholesterol levels as a prognostic factor in gastric cancer patients. J Gastroenterol Hepatol. 27:1635–1640. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Que Y, Jiang F, Liu L, Li Y, Chen Y, Qiu H, Zhou Z and Zhang X: Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma. Medicine (Baltimore). 94:e8442015. View Article : Google Scholar | |
|
Wei LJ, Zhang C, Zhang H, Wei X, Li SX, Liu JT and Ren XB: A case-control study on the association between serum lipid level and the risk of breast cancer. Zhonghua Yu Fang Yi Xue Za Zhi. 50:1091–1095. 2016.In Chinese. | |
|
Cambien F, Ducimetiere P and Richard J: Total serum cholesterol and cancer mortality in a middle-aged male population. Am J Epidemiol. 112:388–394. 1980. View Article : Google Scholar : PubMed/NCBI | |
|
Sherwin RW, Wentworth DN, Cutler JA, Hulley SB, Kuller LH and Stamler J: Serum cholesterol levels and cancer mortality in 361,662 men screened for the multiple risk factor intervention trial. JAMA. 257:943–948. 1987. View Article : Google Scholar : PubMed/NCBI | |
|
Kim TH, Ahn SJ, Jung WT, Lee OJ, Ha WS and Jang JS: Clinical significance of the levels of serum cholesterol in patients with gastric cancer. Cancer Res Treat. 35:335–340. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Ohno Y, Nakashima J, Nakagami Y, Gondo T, Ohori M, Hatano T and Tachibana M: Clinical implications of preopera-tive serum total cholesterol in patients with clear cell renal cell carcinoma. Urology. 83:154–158. 2014. View Article : Google Scholar | |
|
Sok M, Ravnik J and Ravnik M: Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer. Wien Klin Wochenschr. 121:314–317. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Larsen SB, Dehlendorff C, Skriver C, Dalton SQ, Jespersen CG, Borre M, Brasso K, Nørgaard M, Johansen C, Sørensen HT, et al: Postdiagnosis statin use and mortality in danish patients with prostate cancer. J Clin Oncol. 35:3290–3297. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu B, Yi Z, Guan X, Zeng YX and Ma F: The relationship between statins and breast cancer prognosis varies by statin type and exposure time: A meta-analysis. Breast Cancer Res Treat. 164:1–11. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kim HY, Kim DK, Bae SH, Gwak H, Jeon JH, Kim JK, Lee BI, You HJ, Shin DH, Kim YH, et al: Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness. Exp Mol Med. 50:1–12. 2018.PubMed/NCBI | |
|
Ginestier C, Monville F, Wicinski J, Cabaud O, Cervera N, Josselin E, Finetti P, Guille A, Larderet G, Viens P, et al: Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target. Stem Cells. 30:1327–1337. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yang CM, Lu YL, Chen HY and Hu ML: Lycopene and the LXRalpha agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway. J Nutr Biochem. 23:1155–1162. 2012. View Article : Google Scholar | |
|
EL Roz A, Bard JM, Huvelin JM and Nazih H: LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: Relation to proliferation and apoptosis. Anticancer Res. 32:3007–3013. 2012.PubMed/NCBI | |
|
El Roz A, Bard JM, Huvelin JM and Nazih H: The anti-proliferative and pro-apoptotic effects of the trans9, trans11 conjugated linoleic acid isomer on MCF-7 breast cancer cells are associated with LXR activation. Prostaglandins Leukot Essent Fatty Acids. 88:265–272. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Jiang M, Shui Y, Chen Y, Wang Q, Hu W, Ma X, Li X, Liu X, Cao X, et al: DNA topoisomerase II inhibitors induce macro-phage ABCA1 expression and cholesterol efflux-an LXR-dependent mechanism. Biochim Biophys Acta. 1831:1134–1145. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Naren D, Wu J, Gong Y, Yan T, Wang K, Xu W, Yang X, Shi F and Shi R: Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI. Leuk Res. 42:59–67. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kuzu OF, Gowda R, Sharma A and Robertson GP: Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport. Mol Cancer Ther. 13:1690–1703. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gowda R, Inamdar GS, Kuzu O, Dinavahi SS, Krzeminski J, Battu MB, Voleti SR, Amin S and Robertson GP: Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport. Oncotarget. 8:28260–28277. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Rios-Marco P, Martín-Fernández M, Soria-Bretones I, Ríos A, Carrasco MP and Marco C: Alkylphospholipids deregulate cholesterol metabolism and induce cell-cycle arrest and autophagy in U-87 MG glioblastoma cells. Biochim Biophys Acta. 1831:1322–1334. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liu R, Li J, Zhang T, Zou L, Chen Y, Wang K, Lei Y, Yuan K, Li Y, Lan J, et al: Itraconazole suppresses the growth of glioblastoma through induction of autophagy: Involvement of abnormal cholesterol trafficking. Autophagy. 10:1241–1255. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kuzu OF, Gowda R, Noory MA and Robertson GP: Modulating cancer cell survival by targeting intracellular cholesterol transport. Br J Cancer. 117:513–524. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Pelton K, Coticchia CM, Curatolo AS, Schaffner CP, Zurakowski D, Solomon KR and Moses MA: Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo. Am J Pathol. 184:2099–2110. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Lin X, Liu L, Fu Y, Gao J, He Y, Wu Y and Lian X: Dietary cholesterol intake and risk of lung cancer: A meta-analysis. Nutrients. 10:1852018. View Article : Google Scholar : | |
|
Li C, Yang L, Zhang D and Jiang W: Systematic review and meta-analysis suggest that dietary cholesterol intake increases risk of breast cancer. Nutr Res. 36:627–635. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Hu J, La Vecchia C, de Groh M, Negri E, Morrison H and Mery L; Canadian Cancer Registries Epidemiology Research Group: Dietary cholesterol intake and cancer. Ann Oncol. 23:491–500. 2012. View Article : Google Scholar | |
|
Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Beeson WL, Buring JE, Colditz GA, Fraser GE, Freudenheim JL, Goldbohm RA, et al: A pooled analysis of 12 cohort studies of dietary fat, cholesterol and egg intake and ovarian cancer. Cancer Causes Control. 17:273–285. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Solomon KR, Pelton K, Boucher K, Joo J, Tully C, Zurakowski D, Schaffner CP, Kim J and Freeman MR: Ezetimibe is an inhibitor of tumor angiogenesis. Am J Pathol. 174:1017–1026. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Xu X, Han K, Zhu J, Mao H, Lin X, Zhang Z, Cao B, Zeng Y and Mao X: An inhibitor of cholesterol absorption displays anti-myeloma activity by targeting the JAK2-STAT3 signaling pathway. Oncotarget. 7:75539–75550. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Menendez JA, Vellon L and Lupu R: Targeting fatty acid synthase-driven lipid rafts: A novel strategy to overcome trastuzumab resistance in breast cancer cells. Med Hypotheses. 64:997–1001. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Tadros S, Shukla SK, King RJ, Gunda V, Vernucci E, Abrego J, Chaika NV, Yu F, Lazenby AJ, Berim L, et al: De novo lipid synthesis facilitates gemcitabine resistance through endoplasmic reticulum stress in pancreatic cancer. Cancer Res. 77:5503–5517. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Vijayaraghavalu S, Peetla C, Lu S and Labhasetwar V: Epigenetic modulation of the biophysical properties of drug-resistant cell lipids to restore drug transport and endocytic functions. Mol Pharm. 9:2730–2742. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Todor IN, Lukyanova NY and Chekhun VF: The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells. Exp Oncol. 34:97–100. 2012.PubMed/NCBI |
